Lottia digitalis Point on the California coast, "L. digitalis" coexists with the similar species, "Lottia scabra", but each occupies a slightly different habitat. "L. digitalis" tends to occupy vertical rock faces or overhangs and certain horizontal ones clothed by algae and barnacles. "L. digitalis" clump together more often, prefer wave-exposed areas, occupy sites further up the shore and are seldom found in rock pools. Both species move about freely when the tide is up but "L. digitalis" settles in a different location at each low tide whereas "L. scabra" tends to home to the same spot. "L. scabra" has a more rugged
Criticism of the Food and Drug Administration licensing fees to drug manufacturers, which has led to enormous increases in generic drug pricing. In 2013 and 2014, generic drug pricing for over 200 drugs increased over 100%. Many of those drugs had price hikes over 1000%. It has been reported that 75% of the FDA generic drug oversight budget comes directly from private drug companies. A historical example of how the FDA seemingly favors the pharmaceutical industry either from clandestine direct money payments to FDA directors and scientific advisers or other undisclosed or unknown means was seen with the generic drug droperidol. Droperidol was a widely used antiemetic